mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update

Fiona Limanaqi1, Francesca Biagioni2, Carla Letizia Busceti2

  • 1Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Roma 55, 56126 Pisa, Italy.

Insights

Impaired autophagy, a process regulated by mTOR, is linked to epilepsy. Restoring autophagy can prevent seizures, improve behavior, and protect the brain from seizure damage.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Epilepsy Research

Background:

  • Autophagy impairment is increasingly linked to epileptogenesis, particularly in mTORopathies.
  • This cellular process plays a role in various genetic and acquired epilepsy syndromes.

Purpose of the Study:

  • To review the role of autophagy and the ubiquitin-proteasome system in epilepsy.
  • To explore mTOR-dependent cell-clearing mechanisms in seizure-related disorders.

Main Methods:

  • Review of existing evidence on autophagy and epilepsy.
  • Analysis of experimental models demonstrating the effects of autophagy modulation.

Main Results:

  • Autophagy suppression can induce epilepsy, while its restoration prevents epileptogenesis and offers neuroprotection.
  • mTOR-dependent autophagy regulates crucial neuronal functions including progenitor cell migration, synapse development, and excitatory/inhibitory balance via GABAA receptors.

Conclusions:

  • mTOR-dependent autophagy and the ubiquitin-proteasome system are central to epileptogenesis.
  • Understanding these cell-clearing systems offers new insights into epilepsy mechanisms and potential therapeutic targets.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
674
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
741